Skip to content

Upper-Limb rehabilitation in stroke

Efficacy of Piezoelectric Glove and Transcranial Direct Current Stimulation in Upper-Limb rehabilitation in stroke - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068278
Enrollment
81
Registered
2024-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I699- Sequelae of unspecified cerebrovascular diseases

Interventions

Intervention1: Real tDCS + Real Piezoelectric glove + conventional physiotherapy: In this arm, real interventions with both tDCS and Piezoelectric gloves will be given for maximum of 1 month (5 days a

Sponsors

Indian Council of Medical Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18-75 years Chronic stroke (3 months-48 months Ischemic/Hemorrhagic stroke Patient should be conscious, coherent, comprehendible, cooperative Upper limb paresis Clinical evaluation: Mini- Mental Scale (MMSE:24-30) MRC: 1-3 Modified Ashworth Scale (1-3) All patients dwelling within 100km range from Delhi / NCR

Exclusion criteria

Exclusion criteria: History of seizures Recurrent stroke Severe psychiatric or cognitive impairment Contraindications to MRI or tDCS Progressive systemic diseases Not willing to consent Aphasia

Design outcomes

Primary

MeasureTime frame
Change in FMA score at 1 month from baselineTimepoint: Change in FMA score at 1 month from baseline

Secondary

MeasureTime frame
Action research arm test (ARAT) 1,3,6 and 12 monthsTimepoint: 1,3,6 and 12 months;Brunnstrom stage of recovery 1,3,6 and 12 monthsTimepoint: 1,3,6 and 12 months;Change in FMA score at 1 yr from baselineTimepoint: 1 year;Change in FMA score at 3 months from baselineTimepoint: 3 months;Change in FMA score at 6 months from baselineTimepoint: 6 months;fMRI indices BOLD & DTI measures; FA; LI; CST integrityTimepoint: 1, 3, 6 and 12 months;modified Barthel Index (mBI) 1,3,6 and 12 monthsTimepoint: 1,3,6 and 12 months;Quality of Life Scale (SS-QOL) questionnaireTimepoint: 1, 3, 6 and 12 months;Serum BDNF will be estimated at baseline, 4 weeks, 3months, 6 months and 1 year of treatment.Timepoint: Baseline, 4 weeks, 3months, 6 months and 1 year

Countries

India

Contacts

Public ContactVISHNU V Y

AIIMS New Delhi

vishnuvy16@yahoo.com9855480361

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026